Dr Ellen M Kim, MD | |
560 Gage Blvd Ste 206, Richland, WA 99352-8650 | |
(509) 942-3286 | |
(509) 628-1354 |
Full Name | Dr Ellen M Kim |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Experience | 25 Years |
Location | 560 Gage Blvd Ste 206, Richland, Washington |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1124024229 | NPI | - | NPPES |
8458986 | Medicaid | WA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | MD00046853 (Washington) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Tri-cities Home Health | Kennewick, WA | Home health agency |
Columbia River Home Health | Kennewick, WA | Home health agency |
Kadlec Regional Medical Center | Richland, WA | Hospital |
Providence Regional Medical Center Everett | Everett, WA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Kadlec Regional Medical Center | 9739098617 | 338 |
News Archive
The U.S. Food and Drug Administration (FDA) today cleared the OVA1(TM) Test, the first blood test that, prior to surgery, can help physicians determine if a woman is at risk for a malignant pelvic mass. OVA1 is the first FDA-cleared laboratory test that can indicate the likelihood of ovarian cancer with high sensitivity prior to biopsy or exploratory surgery, even if radiological test results fail to indicate malignancy.
A new study finds that Medicare costs tend to be lower in counties with more forests and shrublands than in counties dominated by other types of land cover.
The U.S. Justice Department has accused the Mayo Clinic of submitting false claims to Medicare and other federal programs for lab tests it never performed (Lerner, 12/20).
Actavis, Inc., a leading specialty pharmaceutical company, today announced that is has reached a settlement agreement with Shire plc resolving outstanding patent litigation related to Actavis' generic version of INTUNIV® (guanfacine hydrochloride) for the treatment of Attention Deficit Hyperactivity Disorder.
› Verified 5 days ago
Entity Name | Kadlec Regional Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1972507580 PECOS PAC ID: 9739098617 Enrollment ID: O20031104000035 |
News Archive
The U.S. Food and Drug Administration (FDA) today cleared the OVA1(TM) Test, the first blood test that, prior to surgery, can help physicians determine if a woman is at risk for a malignant pelvic mass. OVA1 is the first FDA-cleared laboratory test that can indicate the likelihood of ovarian cancer with high sensitivity prior to biopsy or exploratory surgery, even if radiological test results fail to indicate malignancy.
A new study finds that Medicare costs tend to be lower in counties with more forests and shrublands than in counties dominated by other types of land cover.
The U.S. Justice Department has accused the Mayo Clinic of submitting false claims to Medicare and other federal programs for lab tests it never performed (Lerner, 12/20).
Actavis, Inc., a leading specialty pharmaceutical company, today announced that is has reached a settlement agreement with Shire plc resolving outstanding patent litigation related to Actavis' generic version of INTUNIV® (guanfacine hydrochloride) for the treatment of Attention Deficit Hyperactivity Disorder.
› Verified 5 days ago
Entity Name | Providence Health & Services- Washington |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1124270715 PECOS PAC ID: 8325100480 Enrollment ID: O20081224000111 |
News Archive
The U.S. Food and Drug Administration (FDA) today cleared the OVA1(TM) Test, the first blood test that, prior to surgery, can help physicians determine if a woman is at risk for a malignant pelvic mass. OVA1 is the first FDA-cleared laboratory test that can indicate the likelihood of ovarian cancer with high sensitivity prior to biopsy or exploratory surgery, even if radiological test results fail to indicate malignancy.
A new study finds that Medicare costs tend to be lower in counties with more forests and shrublands than in counties dominated by other types of land cover.
The U.S. Justice Department has accused the Mayo Clinic of submitting false claims to Medicare and other federal programs for lab tests it never performed (Lerner, 12/20).
Actavis, Inc., a leading specialty pharmaceutical company, today announced that is has reached a settlement agreement with Shire plc resolving outstanding patent litigation related to Actavis' generic version of INTUNIV® (guanfacine hydrochloride) for the treatment of Attention Deficit Hyperactivity Disorder.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Ellen M Kim, MD 550 Gage Blvd Ste 101, Richland, WA 99352-9532 Ph: (509) 942-3627 | Dr Ellen M Kim, MD 560 Gage Blvd Ste 206, Richland, WA 99352-8650 Ph: (509) 942-3286 |
News Archive
The U.S. Food and Drug Administration (FDA) today cleared the OVA1(TM) Test, the first blood test that, prior to surgery, can help physicians determine if a woman is at risk for a malignant pelvic mass. OVA1 is the first FDA-cleared laboratory test that can indicate the likelihood of ovarian cancer with high sensitivity prior to biopsy or exploratory surgery, even if radiological test results fail to indicate malignancy.
A new study finds that Medicare costs tend to be lower in counties with more forests and shrublands than in counties dominated by other types of land cover.
The U.S. Justice Department has accused the Mayo Clinic of submitting false claims to Medicare and other federal programs for lab tests it never performed (Lerner, 12/20).
Actavis, Inc., a leading specialty pharmaceutical company, today announced that is has reached a settlement agreement with Shire plc resolving outstanding patent litigation related to Actavis' generic version of INTUNIV® (guanfacine hydrochloride) for the treatment of Attention Deficit Hyperactivity Disorder.
› Verified 5 days ago
Kalavati Paila, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 888 Swift Blvd., Richland, WA 99352 Phone: 509-946-4611 Fax: 509-942-2185 | |
Dr. Braghadheeswar Thyagarajan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 888 Swift Blvd, Richland, WA 99352 Phone: 509-942-2648 Fax: 509-942-2812 | |
Ziga Tretjak, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 780 Swift Blvd, Suite 270, Kadlec Clinic, Gastroenterology, Richland, WA 99352 Phone: 509-942-3627 Fax: 509-943-3280 | |
Dr. Caleb Haws, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 888 Swift Blvd, Richland, WA 99352 Phone: 509-942-3627 Fax: 509-627-2983 | |
Nazar Hafiz, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1270 Lee Blvd Ste A, Richland, WA 99352 Phone: 509-942-3180 Fax: 509-943-9722 | |
Arnulfo T Deray, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 888 Swift Blvd, Richland, WA 99352 Phone: 509-946-4611 Fax: 509-942-2185 | |
Munish Kumar Kannabhiran, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1100 Goethals Dr Ste E, Richland, WA 99352 Phone: 509-942-3272 Fax: 509-942-3273 |